HomeInsights52 Week Low Stocks

Gland Pharma Ltd 52 Week Low

Gland Pharma Ltd 52 Week Low

stocks purchased

₹ 15.5 Cr

Volume transacted

stocks purchased

85.7 K

stocks traded

Last Updated time: 05 Nov 14:03 PM

Image

Gland Pharma Ltd

NSE: GLAND

YEARLOW

1503.7

Last updated on: Nov 04, 2024

Key Highlights

  • The 52 Week Low of Gland Pharma Ltd is ₹ 1503 as of 04 Nov 24.

Company Fundamentals for Gland Pharma Ltd

No data available

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Gland Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 20241609.85
01 Nov 20241644.85
31 Oct 20241650.85
30 Oct 20241643.05
29 Oct 20241625.35
28 Oct 20241625.1
25 Oct 20241606.15
24 Oct 20241640.9
23 Oct 20241610.15
22 Oct 20241647.1

Asset Value vs Market Value of Gland Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Gland Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Gland Pharma Ltd

No data available

* All values are in crore

Gland Pharma Ltd News Hub

News

Gland Pharma soars as Q2 PAT rises 9% YoY to Rs 282 cr

On consolidated basis, the firm's net profit declined 15.74% to Rs 163.53 crore on 2.36% t...

Read more

05 Nov 202410:42

News

Volumes jump at Gland Pharma Ltd counter

Chemplast Sanmar Ltd, Hatsun Agro Product Ltd, ABB India Ltd, Bata India Ltd are among the...

Read more

05 Nov 202411:00

News

Gland Pharma to hold board meeting

Gland Pharma will hold a meeting of the Board of Directors of the Company on 4 November 20...

Read more

23 Oct 202410:19

News

Gland Pharma Ltd slips for fifth straight session

Gland Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 18...

Read more

19 Sep 202413:35

News

Gland Pharma Ltd gains for third straight session

Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 193...

Read more

09 Sep 202413:05

News

Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr

Revenue from operations jumped 15.97% YoY to Rs 1,401.70 crore in Q1 FY25. Profit before t...

Read more

07 Aug 202411:27

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week Low of Gland Pharma Ltd

Why is it important to track the 52-week low of Gland Pharma Ltd stocks?

Investors should monitor the 52-week low of Gland Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Gland Pharma Ltd stocks hitting a 52-week low?

Factors leading to Gland Pharma Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Gland Pharma Ltd stocks when they hit a 52-week low?

Buying Gland Pharma Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Gland Pharma Ltd stocks?

Investors should monitor the 52-week low of Gland Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Gland Pharma Ltd stock at their 52-week low?

An investor can analyze the reasons for the Gland Pharma Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Gland Pharma Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Gland Pharma Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Gland Pharma Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*